» Articles » PMID: 23160217

Re(de)fining the Dendritic Cell Lineage

Overview
Journal Nat Immunol
Date 2012 Nov 20
PMID 23160217
Citations 232
Authors
Affiliations
Soon will be listed here.
Abstract

Dendritic cells (DCs) are essential mediators of innate and adaptive immune responses. Study of these critical cells has been complicated by their similarity to other hematopoietic lineages, particularly monocytes and macrophages. Progress has been made in three critical areas of DC biology: the characterization of lineage-restricted progenitors in the bone marrow, the identification of cytokines and transcription factors required during differentiation, and the development of genetic tools for the visualization and depletion of DCs in vivo. Collectively, these advances have clarified the nature of the DC lineage and have provided novel insights into their function during health and disease.

Citing Articles

From tumor microenvironment to emerging biomarkers: the reshaping of the esophageal squamous cell carcinoma tumor microenvironment by neoadjuvant chemotherapy combined with immunotherapy.

Qiu Z, Li Z, Liu X, Zhang R, Li Y, Gao C Front Immunol. 2024; 15:1478922.

PMID: 39703499 PMC: 11655454. DOI: 10.3389/fimmu.2024.1478922.


Targeting Immune Cells.

Seydoux E, Fytianos K, von Garnier C, Rothen-Rutishauser B, Blank F J Aerosol Med Pulm Drug Deliv. 2024; 37(6):328-337.

PMID: 39625807 PMC: 11684560. DOI: 10.1089/jamp.2024.63954.es.


Degradation of PARP1 by MARCHF3 in tumor cells triggers cCAS-STING activation in dendritic cells to regulate antitumor immunity in hepatocellular carcinoma.

Cao J, Su B, Zhang C, Peng R, Tu D, Deng Q J Immunother Cancer. 2024; 12(11).

PMID: 39608977 PMC: 11605840. DOI: 10.1136/jitc-2024-010157.


The interaction of innate immune and adaptive immune system.

Wang R, Lan C, Benlagha K, Camara N, Miller H, Kubo M MedComm (2020). 2024; 5(10):e714.

PMID: 39286776 PMC: 11401974. DOI: 10.1002/mco2.714.


The Multifaceted Functionality of Plasmacytoid Dendritic Cells in Gastrointestinal Cancers: A Potential Therapeutic Target?.

Hansen F, David P, Weber G Cancers (Basel). 2024; 16(12).

PMID: 38927922 PMC: 11201847. DOI: 10.3390/cancers16122216.


References
1.
Manicassamy S, Reizis B, Ravindran R, Nakaya H, Salazar-Gonzalez R, Wang Y . Activation of beta-catenin in dendritic cells regulates immunity versus tolerance in the intestine. Science. 2010; 329(5993):849-53. PMC: 3732486. DOI: 10.1126/science.1188510. View

2.
Iacobelli M, Wachsman W, McGuire K . Repression of IL-2 promoter activity by the novel basic leucine zipper p21SNFT protein. J Immunol. 2000; 165(2):860-8. DOI: 10.4049/jimmunol.165.2.860. View

3.
Traver D, Akashi K, Manz M, Merad M, Miyamoto T, Engleman E . Development of CD8alpha-positive dendritic cells from a common myeloid progenitor. Science. 2000; 290(5499):2152-4. DOI: 10.1126/science.290.5499.2152. View

4.
Sathe P, Pooley J, Vremec D, Mintern J, Jin J, Wu L . The acquisition of antigen cross-presentation function by newly formed dendritic cells. J Immunol. 2011; 186(9):5184-92. DOI: 10.4049/jimmunol.1002683. View

5.
Hashimoto D, Miller J, Merad M . Dendritic cell and macrophage heterogeneity in vivo. Immunity. 2011; 35(3):323-35. PMC: 4520532. DOI: 10.1016/j.immuni.2011.09.007. View